本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Stoke Therapeutics, Inc.

27.91
-0.2400-0.85%
盤後28.000.0900+0.32%17:31 EDT
成交量:58.95萬
成交額:1,647.67萬
市值:18.01億
市盈率:-8.38
高:28.60
開:28.25
低:27.66
收:28.15
52周最高:40.22
52周最低:20.32
股本:6,452.62萬
流通股本:4,901.27萬
量比:0.90
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-3.3325
每股收益(LYR):-0.1163
淨資產收益率:-61.10%
總資產收益率:-35.87%
市淨率:5.21
市盈率(LYR):-240.06

資料載入中...

2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/18

SEC問詢函

Form CORRESP - Correspondence